We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
OneWater Marine
ONEW
$161M
| $1.11M | ﹤0.01% |
98,238
+34,483
| +54% | +$371K |
2025 Q1
5 quarters
|
|
2952
MVB Financial
MVBF
$330M
| $1.11M | ﹤0.01% |
38,132
+5,507
| +17% | +$146K |
2025 Q2
4 quarters
|
|
2953
Shenandoah Telecom
SHEN
$563M
| $1.1M | ﹤0.01% |
+73,134
| New | +$1.15M |
2026 Q2
0 quarters
|
|
2954
Rapport Therapeutics
RAPP
$1.2B
| $1.1M | ﹤0.01% |
26,454
+944
| +4% | +$34.7K |
2025 Q2
4 quarters
|
|
2955
Acacia Research
ACTG
$423M
| $1.1M | ﹤0.01% |
236,392
+154,684
| +189% | +$743K |
2025 Q1
5 quarters
|
|
2956
Oak Valley Bancorp
OVLY
$290M
| $1.1M | ﹤0.01% |
32,551
+12,929
| +66% | +$436K |
2025 Q2
4 quarters
|
|
2957
Kymera Therapeutics
KYMR
$10.8B
| $1.09M | ﹤0.01% |
9,541
-6,410
| -40% | -$551K |
2025 Q2
4 quarters
|
|
2958
Fidelity Total Bond ETF
FBND
$28.5B
| $1.09M | ﹤0.01% |
24,005
+3,835
| +19% | +$175K |
2023 Q4
10 quarters
|
|
2959
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.13B
| $1.09M | ﹤0.01% |
7,935
+4,059
| +105% | +$515K |
2025 Q2
4 quarters
|
|
|
TWO
2960
DELISTED
Two Harbors Investment
TWO
| $1.09M | ﹤0.01% |
87,661
-36,992
| -30% | -$443K |
2025 Q1
5 quarters
|
|
2961
Groupon
GRPN
$640M
| $1.08M | ﹤0.01% |
45,075
+24,841
| +123% | +$410K |
2025 Q1
5 quarters
|
|
2962
Alpha Architect US Equity 2 ETF
AAEQ
$503M
| $1.08M | ﹤0.01% |
20,340
-1,612
| -7% | -$83.4K |
2026 Q1
1 quarter
|
|
2963
INmune Bio
INMB
$40.5M
| $1.08M | ﹤0.01% |
662,218
+391,901
| +145% | +$542K |
2025 Q3
3 quarters
|
|
2964
Futu Holdings
FUTU
$13.8B
| $1.08M | ﹤0.01% |
11,508
-18,297
| -61% | -$2.34M |
2025 Q1
5 quarters
|
|
2965
Invesco Large Cap Value ETF
PWV
$1.89B
| $1.08M | ﹤0.01% |
14,224
| – | – |
2025 Q1
5 quarters
|
|
2966
Vanguard Tax-Exempt Bond Index Fund
VTEB
$51.3B
| $1.08M | ﹤0.01% |
21,283
-2,668
| -11% | -$134K |
2024 Q2
8 quarters
|
|
2967
CarGurus
CARG
$2.87B
| $1.07M | ﹤0.01% |
31,505
-116,578
| -79% | -$3.78M |
2020 Q3
23 quarters
|
|
2968
Sabesp
SBS
$16B
| $1.07M | ﹤0.01% |
185,368
+20,183
| +12% | +$122K |
2013 Q2
52 quarters
|
|
2969
Inhibrx
INBX
$1.06B
| $1.07M | ﹤0.01% |
11,247
+2,867
| +34% | +$287K |
2025 Q3
3 quarters
|
|
2970
Rush Enterprises Class B
RUSHB
$6.62B
| $1.06M | ﹤0.01% |
20,874
+5,136
| +33% | +$239K |
2025 Q1
5 quarters
|
|
2971
BlackRock Flexible Income ETF
BINC
$16.6B
| $1.06M | ﹤0.01% |
20,251
-555
| -3% | -$29K |
2024 Q3
7 quarters
|
|
2972
LCNB Corp
LCNB
$281M
| $1.06M | ﹤0.01% |
60,253
+21,593
| +56% | +$360K |
2025 Q3
3 quarters
|
|
2973
DELISTED
Apogee Therapeutics
APGE
| $1.06M | ﹤0.01% |
7,958
-69
| -0.9% | -$6.22K |
2026 Q1
1 quarter
|
|
2974
TPG
TPG
$8.42B
| $1.06M | ﹤0.01% |
26,377
-9,868
| -27% | -$415K |
2025 Q2
4 quarters
|
|
2975
Caris Life Sciences
CAI
$9.7B
| $1.05M | ﹤0.01% |
59,103
+30,109
| +104% | +$539K |
2026 Q1
1 quarter
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.